Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?

Front Neurol. 2020 Apr 3:11:171. doi: 10.3389/fneur.2020.00171. eCollection 2020.

Johannes Boltze¹, Koji Abe², Andrew N Clarkson³, Oliver Detante^{4

5}, Pedro M Pimentel-Coelho^{6

7}, Paulo H Rosado-de-Castro^{8

9

10}, Miroslaw Janowski^{11

12}

¹ School of Life Sciences, University of Warwick, Coventry, United Kingdom.
² Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
³ Department of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand.
⁴ Stroke Unit, Neurology Department, Grenoble Hospital, Grenoble, France.
⁵ Grenoble Institute of Neurosciences, Inserm U1216, Université Grenoble Alpes, Grenoble, France.
⁶ Instituto de Biofísica Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁷ Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa, Rio de Janeiro, Brazil.
⁸ Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁹ Department of Radiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
¹⁰ D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
¹¹ Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.
¹² NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.

No abstract available

Keywords: brain; clinical trials; ischemia; mesenchymal stem cells (MSC); stem cells; stroke; translational medicine; treatment.

Publication types